...
首页> 外文期刊>Bioinorganic chemistry and applications >Synthesis andin vitroAntitumor Potency of(Cyclohexane-1,2-Diamine)Platinum(II) Complexeswith Aminotris(Methylenephosphonic Acid) as Bone-Seeking Ligand
【24h】

Synthesis andin vitroAntitumor Potency of(Cyclohexane-1,2-Diamine)Platinum(II) Complexeswith Aminotris(Methylenephosphonic Acid) as Bone-Seeking Ligand

机译:氨基三(亚甲基膦酸)为骨架配体的(环己烷-1,2-二胺)铂(II)配合物的合成及体外抗肿瘤活性

获取原文
           

摘要

In order to develop platinum complexes with selective activity in primary and secondary bonemalignancies and with the aim to optimize antitumor activity, platinum(II) complexes withaminotris(methylenephosphonic acid) as bone-seeking (osteotropic) ligand have been synthesized,characterized and tested in the cisplatin-sensitive ovarian carcinoma cell line CH1. As non-leaving diamineligands, which are decisive for the cellular processing of DNA adducts,cis-R,S-cyclohexane-1,2-diamine,trans-S,S-cyclohexane-1,2-diamine andtrans-R,R-cyclohexane-1,2-diamine have been used, resulting incomplexes 1, 2, and 3, respectively. The cytotoxicity of the complexes under investigation decreases in theorder 3>2>1 which is in accord with structure-activity relationships with other (cyclohexane-1,2-diamine)platinum(II) and platinum(IV) complexes: Bothtranscomplexes (2 and 3) display a higherin vitropotency than the correspondingcisisomer (I), with thetrans-R,Risomer (3) being the most active in thisseries. In comparison to the analogous (cyclohexane-1,2-diamine)platinum(II) complexes withbis(phosphonomethyl)aminoacetic acid as osteotropic carrier ligand, the cytotoxicity of 1-3 was found to be1.5 – 2 fold higher, which is explainable by a different coordination mode of the phosphonic acid ligands(acetato versus phosphonato).
机译:为了开发在原发性和继发性骨恶性肿瘤中具有选择性活性的铂配合物,并以优化抗肿瘤活性为目的,已合成,表征和测试了氨基三(亚甲基膦酸)作为骨寻找(促骨性)配体的铂(II)配合物。顺铂敏感性卵巢癌细胞系CH1。作为对DNA加合物的细胞加工起决定性作用的非离去二胺配体,顺式-R,S-环己烷-1,2-二胺,反式-S,S-环己烷-1,2-二胺和反式-R,R-已使用环己烷-1,2-二胺,分别形成复合物1、2和3。研究中的复合物的细胞毒性以3> 2> 1的顺序降低,这与与其他(环己烷-1,2-二胺)铂(II)和铂(IV)配合物的结构-活性关系相符:两种反式配合物(2和3)显示出比相应的顺式异构体(I)更高的体外效能,其中反式-R,顺式异构体(3)在该系列中最活跃。与具有双(膦酰基甲基)氨基乙酸作为亲骨载体配体的类似(环己烷-1,2-二胺)铂(II)配合物相比,发现1-3的细胞毒性高1.5-2倍,这是可以解释的通过膦酸配体的不同配位模式(乙酰基对膦酸基)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号